Tom Hullinger

Tom Hullinger has held a variety of roles in the pharmaceutical industry since 1991. Theircareer began at Pharmacia and Upjohn as a Researcher. Tom then moved to UCB Research in 2001 as a Senior Scientist, where they were responsible for leading the pulmonary mucus program. In 2004, they joined Novartis as a Research Investigator II, where they served as a program manager. From 2009 to 2014, Tom worked at both Gilead Sciences as a Research Scientist and miRagen Therapeutics as a Research Scientist III, where they were the project team leader and a member of the Joint Research Committee for collaboration with large pharma. From 2014 to 2016, they were the Senior Director of Translational Research at ProNAi Therapeutics, Inc., where they directed drug discovery strategy and execution. Tom then moved to Inotiv in 2019 as a Study Director, and is currently the Sr. Director of Pharmacology and Therapeutics at TriSalus Life Sciences.

Tom Hullinger obtained their PhD in Pharmacology from the University of Michigan in 1999.